Endocrinology Vol. 139, No. 8 3512-3519
Copyright © 1998 by The Endocrine Society
17ß-Estradiol Potentiates the Stimulatory Effects of Progesterone on Cadherin-11 Expression in Cultured Human Endometrial Stromal Cells1
George T. C. Chen,
Spiro Getsios and
Colin D. MacCalman
Department of Obstetrics and Gynecology, University of British
Columbia, Vancouver, British Columbia, Canada V6H 3V5
Address all correspondence and requests for reprints to: Dr. Colin D. MacCalman, Department of Obstetrics and Gynecology, Faculty of Medicine, University of British Columbia, 2H304490 Oak Street, Vancouver, British Columbia, Canada V6H 3V5. E-mail:
colinmac{at}interchange.ubc.ca
 |
Abstract
|
|---|
Cadherin-11 (cad-11) is a novel member of the cadherin gene superfamily
of calcium-dependent cell adhesion molecules. To date, the factors
capable of regulating this cell adhesion molecule remain poorly
characterized. We have recently determined that cad-11 expression in
the human endometrium is tightly regulated during the menstrual cycle.
The spatiotemporal expression of cad-11 in the stromal cells of the
human endometrium during the menstrual cycle suggests that gonadal
steroids regulate the expression of this endometrial cell adhesion
molecule. In view of these observations, we have examined the ability
of progestins, estrogens, and androgens, alone or in combination, to
regulate cad-11 expression in isolated human endometrial stromal cells
using Northern and Western blot analyses. In these studies, we have
determined that progesterone, but not 17ß-estradiol or
dihydrotestosterone, is capable of regulating cad-11 messenger RNA and
protein expression levels in isolated endometrial stromal cells. In
addition, 17ß-estradiol, but not dihydrotestosterone, was capable of
potentiating the stimulatory effects of progesterone in a
dose-dependent manner. Taken together, these observations suggest that
both 17ß-estradiol and progesterone are required for maximal cad-11
expression in human endometrial stromal cells in vitro.
 |
Introduction
|
|---|
GONADAL steroids are key regulators of the
cyclic remodeling processes that occur in the human endometrium during
the menstrual cycle. It has been well established that 17ß-estradiol
(E2) promotes cellular proliferation in the
stroma and glandular epithelium of the endometrium (1, 2). Progesterone
(P4) in turn, is believed to act upon the
E2-primed endometrium, thereby initiating
glandular secretion and the terminal differentiation of stromal cells
into decidual cells (1). However, recent studies also suggest that the
nonaromatizable androgen, dihydrotestosterone (DHT), is capable of
mediating decidualization in human endometrial stromal cells in
vitro (3, 4). The molecular and cellular mechanisms by which
gonadal steroids regulate the differentiation of endometrial stromal
cells into decidual cells remain poorly understood.
We have recently determined that cadherin-11 (cad-11), a novel member
of the gene superfamily of calcium-dependent cell adhesion molecules
known as the cadherins, is spatiotemporally expressed in the human
endometrium (5). In particular, cad-11 is first detected in the
endometrial stroma during the late secretory phase of the menstrual
cycle when these cells are beginning to undergo decidualization.
Maximum cad-11 levels are expressed in the decidua of early pregnancy
(5, 6). Taken together, these observations suggest that cad-11
expression is associated with the terminal differentiation of
endometrial stromal cells into decidual cells. To date, the factors
capable of regulating cad-11 expression have not been identified.
The spatiotemporal expression of cad-11 in endometrial stromal cells
during the menstrual cycle suggests that this cell adhesion molecule is
hormonally regulated. We have previously demonstrated that gonadal
steroids are key regulators of cadherin expression in murine tissues.
For example, P4 and E2 were
capable of increasing E-cadherin (E-cad) messenger RNA (mRNA) levels in
the immature mouse uterus (7), whereas only E2
(but not P4, testosterone, or DHT) increased
E-cad mRNA levels in the immature mouse ovary (8). Similarly, only
E2 was capable of stimulating N-cadherin (N-cad)
mRNA levels in the immature mouse ovary and testis in vivo
(9). These observations have led us to hypothesize that the ability of
steroids to regulate the developmental processes that occur in
reproductive tissues may be mediated at least in part by their ability
to modulate cadherin expression.
Previous studies have demonstrated that gonadal steroids can induce
cellular differentiation in endometrial stromal cells in
vitro (3, 10, 11). In view of these observations, we have examined
the ability of estrogens, progestins, and androgens, alone or in
combination, to regulate cad-11 expression in isolated endometrial
stromal cells using Northern and Western blot analyses. In these
studies, we have determined that P4, but not
E2 or DHT, is capable of regulating cad-11
expression in human endometrial stromal cells. However, maximum levels
of cad-11 mRNA and protein levels were detected in stromal cells
cultured in the presence of E2 and
P4, suggesting that E2
enhances the P4-mediated increase in stromal
cad-11 expression. In contrast, DHT was not capable of potentiating the
stimulatory effects of P4 on stromal cad-11
expression.
 |
Materials and Methods
|
|---|
Tissues
Endometrial tissue biopsy specimens (n = 15) were obtained
from women of reproductive age in accordance with a protocol for the
use of human tissues approved by the committee for ethical review of
research involving human subjects, University of British Columbia. All
patients had normal menstrual cycles and had not received hormones for
at least 3 months before the collection of the tissues. The stage of
the menstrual cycle was determined by the last menses and was confirmed
by histological evaluation according to the criteria of Noyes et
al. (1). Tissues used in this study were obtained during the
midsecretory phase of the menstrual cycle.
Cell preparation and culture
The endometrial stromal cells were separated from the glandular
epithelium by enzymatic digestion and mechanical dissociation using a
protocol modified from that reported by Shiokawa et al.
(12). Briefly, the endometrial biopsy specimens were minced and
subjected to 0.1% collagenase (type IA, Sigma Chemical Co., St. Louis,
MO) and 0.1% hyaluronidase (type I-S, Sigma Chemical Co.) digestion in
a shaking water bath at 37 C for 1 h. The cell digest was then
passed through a nylon sieve (38 µm). The isolated glands were
retained on the sieve, and the eluate containing the stromal cells was
collected in a 50-ml tube. The stromal cells were pelleted by
centrifugation at 800 x g for 10 min at room
temperature. The cell pellet was washed once in phenol red-free DMEM
containing 10% charcoal-stripped FBS before being resuspended and
plated in phenol red-free DMEM containing 25 mM glucose, 25
mM HEPES, 1% (wt/vol) L-glutamine, antibiotics
(100 U/ml penicillin, 100 µg/ml streptomycin, and 2.5 µg/ml
fungizone) and supplemented with 10% charcoal-stripped FBS. The
culture medium was replaced 30 min after plating to reduce epithelial
cell contamination. The purity of the cell cultures was determined by
immunocytochemical staining for vimentin, cytokeratin, muscle actin,
and factor VIII (data not shown). These cellular markers have been
previously used to determine the purity of human endometrial cell
cultures (11). As defined by these criteria, the endometrial stromal
cell cultures used in these studies contained less than 1% of
endometrial epithelial or vascular cells.
Hormone treatments
The stromal cells (passage 2) were grown to confluence, washed
with PBS, and cultured in phenol red-free DMEM supplemented with 10%
charcoal-stripped FBS and containing P4 (1
µM), E2 (30 nM), DHT
(0.1 µM) or vehicle (0.1% ethanol). The concentrations
of hormones used in these experiments were selected on the basis of
previous studies (4, 11, 13). The cells were cultured in the presence
or absence of the steroids for 096 h before being harvested for
Northern or Western blot analysis. In these and the following studies,
the culture medium was changed every 24 h.
To determine whether a combination of steroids was required for maximal
cad-11 expression in endometrial stromal cells, the cells were cultured
in the presence of P4 (1 µM) plus
E2 (30 nM) or
P4 (1 µM) plus DHT (0.1
µM) for 096 h before being harvested for Northern or
Western blot analysis.
Finally, to determine whether the ability of E2
to potentiate the effects of P4 on stromal cad-11
expression was dose dependent, the cells were cultured in the presence
of vehicle (0.1% ethanol), E2 (30
nM), P4 (1 µM) or
P4 (1 µM) plus varying doses of
E2 (0.5100 nM) for 96 h. The
cells were then harvested for Northern or Western blot analysis.
Northern blot analysis
Total RNA was prepared from the cultured stromal cells by the
phenol-chloroform method of Chomczynski and Sacchi (14). The RNA
species were resolved by electrophoresis in 1% agarose gels containing
3.7% formaldehyde. Approximately 20 µg total RNA were loaded per
lane. The fractionated RNA species were then transferred onto charged
nylon membranes.
The Northern blots were hybridized with a radiolabeled complementary
DNA probe specific for human cad-11 according to the methods of
MacCalman et al. (15). The blots were then washed twice with
2 x SSPE (20 x SSPE consists of 0.2 M sodium
phosphate, pH 7.4, containing 25 mM EDTA and 3
M NaCl) at room temperature, twice with 2 x SSPE
containing 1% SDS at 55 C, and twice with 0.2 x SSPE at room
temperature. To standardize the amounts of total RNA in each lane, the
blots were probed with a radiolabeled synthetic oligonucleotide
specific for 18S ribosomal RNA (rRNA) as described by MacCalman
et al. (15). The blots were again subjected to
autoradiography to detect the hybridization of the radiolabeled probe
to the 18S rRNA. The autoradiograms were then scanned using an LKB
laser densitometer (LKB, Rockville, MD). The absorbance values obtained
for the cad-11 mRNA transcript were normalized relative to the
corresponding 18S rRNA absorbance value.
Western blot analysis
For Western blot analysis, the stromal cells were washed with
PBS and incubated in 100 µl chilled cell lysis buffer (Tris-HCl, pH
7.5, containing 0.5% Nonidet P-40, 0.5 mM
CaCl2, and 1.0 mM PMSF) at 4 C for 30 min on a
rocking platform. The cell lysates were centrifuged at 10,000 x
g for 20 min, and the supernatant was used in the Western
blot analyses. Aliquots (20 µg) were subjected to SDS-PAGE under
reducing conditions, as described by Laemmli (16). The stacking gels
contained 5% acrylamide, and the separating gels were composed of
7.5% acrylamide. The proteins were electrophoretically transferred
from the gels onto nitrocellulose paper according to the procedures of
Towbin et al. (17). The nitrocellulose blots were probed
with a mouse monoclonal antibody (C11-113H) directed against human
cad-11 (ICOS Corp., Bothell, WA). The Amersham ECL system (Amersham,
Arlington Heights, IL) was used to detect antibody bound to antigen.
The autoradiograms were then scanned using an LKB laser
densitometer.
Statistical analysis
The results are presented as the mean relative absorbance
(±SE) for at least three independent experiments.
Statistical differences between time points and treatments were
assessed by ANOVA. Differences were considered significant for
P < 0.05. Significant differences between the means
were determined using the least significant test.
 |
Results
|
|---|
Effects of gonadal steroids on stromal cad-11 mRNA and protein
levels
A single cad-11 mRNA transcript of 4.4 kb was detected in all of
the total RNA extracts prepared from the cultured endometrial stromal
cells. The addition of vehicle (0.1% ethanol) to the culture medium
had no significant effect on the levels of the cad-11 mRNA transcript
present in these endometrial stromal cell cultures (Fig. 1A
). In contrast,
P4 caused a significant increase in the stromal
cad-11 mRNA levels after 24 h of culture in the presence of this
steroid (Fig. 1B
). The levels of the cad-11 mRNA transcript continued
to increase until the end of these studies at 96 h.
E2, or DHT alone did not significantly increase
cad-11 mRNA levels at any of the time points examined in these studies
(Fig. 1
, C and D, respectively).

View larger version (45K):
[in this window]
[in a new window]
|
Figure 1. Autoradiograms of Northern blots containing total
RNA extracted from isolated stromal cells cultured in the presence of
vehicle (A), 1 µM P4 (B), 30 nM
E2 (C), or 0.1 µM DHT (D). The cells were
harvested 0, 6, 12, 24, 48, 72, or 96 h after treatment (lanes
ag, respectively). The blots were probed for cad-11
(top) or 18S rRNA (bottom). The
autoradiograms were scanned using a laser densitometer. The absorbance
values obtained for the cad-11 mRNA transcript were then normalized to
the values obtained for the 18S rRNA. The results derived from this
analysis as well as those from two other studies (autoradiograms not
shown) were standardized to the 0 h control and are represented
(mean ± SEM; n = 3) in the bar
graphs. *, P < 0.05.
|
|
Western blot analysis, using extracts prepared from endometrial stromal
cells cultured in the presence or absence of gonadal steroids and a
mouse monoclonal antibody directed against human cad-11, revealed a
single cad-11 protein species (Mr, 125 kDa)
in all of the cellular extracts. In agreement with the Northern blot
analysis, the addition of vehicle to the culture medium did not
significantly alter cad-11 expression levels in the endometrial cell
cultures (Fig. 2A
). Similarly,
P4 caused an increase in cad-11 expression after
24 h of culture in the presence of this steroid (Fig. 2B
). The
expression levels of cad-11 continued to increase until the end of
these experiments at 96 h. In addition, we failed to detect a
significant increase in cad-11 expression levels in endometrial stromal
cells cultured in the presence of E2 or DHT at
any of the time points examined in these studies (Fig. 2
, C and D,
respectively).

View larger version (42K):
[in this window]
[in a new window]
|
Figure 2. Western blot analysis of cad-11 expression levels
in isolated stromal cells cultured in the presence of vehicle (A), 1
µM P4 (B), 30 nM E2
(C), or 0.1 µM DHT (D). Twenty micrograms of protein
extracted from endometrial stromal cells cultured for 0, 6, 12, 24, 48,
72, or 96 h in the presence or absence of steroids were loaded in
each lane (lanes ag, respectively). Western blot analysis was
performed using a mouse monoclonal antibody directed against human
cad-11. The Amersham ECL system was used to detect antibody bound to
antigen. The autoradiograms were then scanned using an LKB laser
densitometer. The results derived from this analysis as well as those
from three other studies (autoradiograms not shown) were standardized
to the 0 h control and are represented (mean ±
SEM; n = 4) in the bar graphs. *,
P < 0.05.
|
|
Effects of P4 plus
E2 or DHT on cad-11 mRNA and protein levels in
endometrial stromal cells
There was a significant increase in cad-11 mRNA and protein
expression levels in endometrial stromal cells cultured in the presence
of E2 plus P4 for 12 h
(Fig. 3A
). Similarly,
stromal cad-11 protein expression levels were significantly increased
after 12 h of culture under these conditions (Fig. 3B
). Cad-11
mRNA and protein expression levels continued to increase until the end
of these studies at 96 h (Fig. 3
, A and B, respectively). The
cad-11 mRNA and protein levels detected in the endometrial stromal
cells cultured in the presence of E2 plus
P4 for 1296 h were significantly greater than
those observed in cells cultured in P4 for the
same periods of time (P < 0.05).

View larger version (20K):
[in this window]
[in a new window]
|
Figure 3. The effects of E2 on the
P4-mediated increase in stromal cad-11 mRNA levels (A) or
protein expression levels (B). Stromal cells were cultured in the
presence of 1 µM P4 plus 30 nM
E2 for 0, 6, 12, 24, 48, 72, or 96 h (lanes ag)
before being harvested for Northern or Western blot analysis. A,
Autoradiograms of a Northern blot containing total RNA extracted from treated
endometrial stromal cells and probed for cad-11 (top) or
18S rRNA (bottom). The absorbance values obtained from
this study as well as those from two other studies (autoradiograms not
shown) were standardized to the 0 h control and are
represented (mean ± SEM; n = 3) in the
bar graphs. *, P < 0.05. B,
Autoradiogram of a Western blot containing protein extracted from the
treated endometrial stromal cells and probed with a mouse monoclonal
antibody directed against human cad-11. The Amersham ECL system was
used to detect antibody bound to antigen. The absorbance values
obtained from this study as well as those from three other studies
(autoradiograms not shown) were standardized to the 0 h control
and are represented (mean ± SEM; n = 4) in the
bar graphs. *, P < 0.05.
|
|
In contrast, there was no significant difference between the cad-11
mRNA and protein levels observed in cells cultured in the presence of
P4 plus DHT and those detected in cells cultured
in P4 alone at any time point examined in these
studies (P < 0.05; Figs 4
, A and B,
respectively).

View larger version (20K):
[in this window]
[in a new window]
|
Figure 4. Effects of DHT on the P4-mediated
increase in stromal cad-11 mRNA levels (A) or protein expression levels
(B). Stromal cells were cultured in the presence of 1 µM
P4 plus 0.1 µM DHT for 0, 6, 12, 24, 48, 72,
or 96 h (lanes ag) before being harvested for
Northern or Western blot analysis. A, Autoradiograms of a Northern blot
containing total RNA extracted from the treated endometrial stromal
cells and probed for cad-11 (top) or 18S rRNA
(bottom). The absorbance values obtained from this study
as well as those from two other studies (autoradiograms not shown) were
standardized to the 0 h control and are represented
(mean ± SEM; n = 3) in the bar
graphs. *, P < 0.05. B, Autoradiogram of a
Western blot containing 20 µg protein extracted from the treated
endometrial stromal cells and probed with a mouse monoclonal antibody
directed against human cad-11. The Amersham ECL system was used to
detect antibody bound to antigen. The absorbance values obtained from
this study as well as those from three other studies (autoradiograms
not shown) were standardized to the 0 h control and are
represented (mean ± SEM; n = 4) in the
bar graphs. *, P < 0.05.
|
|
Effects of varying doses of E2 to
potentiate the P4-mediated increase in stromal
cad-11 mRNA and protein levels
To determine whether the ability of E2 to
potentiate the P4-mediated increase in cad-11
expression was dose dependent, the stromal cells were cultured in the
presence of P4 plus varying doses of
E2 (0.5100 nM; Fig. 5
). Increasing doses of
E2 progressively enhanced the effects of
P4 on stromal cad-11 mRNA and protein levels
(Fig. 5
, A and B, respectively). Maximum cad-11 mRNA and protein
expression levels were observed in cells cultured in the presence of 30
nM E2. There was no further
enhancement in stromal cad-11 mRNA and protein expression levels when
the concentration of E2 was increased to 100
nM (Fig. 5
, A and B, respectively).

View larger version (24K):
[in this window]
[in a new window]
|
Figure 5. Effects of varying concentrations of
E2 on the P4-mediated increase in stromal
cad-11 mRNA levels (A) or protein expression levels (B). Stromal cells
were cultured in the presence of vehicle, 30 nM
E2, 1 µM P4, or 1
µM P4 plus 0.5, 1, 5, 10, 30, or 100
nM E2 (lanes ai, respectively) for 96 h
before being harvested for Northern or Western blot analysis. A,
Autoradiograms of Northern blots containing total RNA extracted from
the treated stromal cells and probed for cad-11 (top) or
18S rRNA (bottom). The absorbance values obtained from
this study as well as those from two other studies (autoradiograms not
shown) were standardized to the vehicle control and are
represented (mean ± SEM; n = 3) in the
bar graphs. *, P < 0.05. B,
Autoradiograms of Western blots containing 20 µg protein extracted
from the treated stromal cells and probed with a mouse monoclonal
antibody directed against human cad-11. The Amersham ECL system was
used to detect antibody bound to antigen. The absorbance values
obtained from this study as well as those from three other studies
(autoradiograms not shown) were standardized to the vehicle control and
are represented (mean ± SEM; n = 4) in the
bar graphs. *, P < 0.05.
|
|
 |
Discussion
|
|---|
A single cad-11 mRNA transcript of 4.4 kb was detected in all of
the total RNA extracts prepared from the cultured endometrial stromal
cells. This cad-11 mRNA transcript has been previously detected in RNA
extracts prepared from a range of human tissues, including endometrium,
placenta, and ovary (5, 6, 18). Similarly, the single cad-11 protein
species (Mr, 125 kDa) detected in the stromal
cell extracts using Western blot analysis has been observed in total
cellular extracts prepared from choriocarcinoma cells (5). The present
studies demonstrate that P4, but not
E2 or DHT, is capable of regulating cad-11 mRNA
and protein levels in endometrial stromal cells in vitro. In
addition, the P4-mediated increase in stromal
cad-11 mRNA and protein expression levels can be further enhanced by
the addition of E2 to the culture medium. These
observations indicate that both gonadal steroids are required for
maximal cad-11 expression in human endometrial stromal cells.
Long term culture of endometrial stromal cells in the presence of
P4 has been shown to modulate the expression of
endometrial proteins associated with the remodeling processes that
occur in the endometrium during the late secretory phase of the
menstrual cycle. For example, P4 has been shown
to stimulate fibronectin production in endometrial stromal cells (19),
a key component of the decidual extracellular matrix (20), and suppress
the expression of endometrial metalloproteinases, which are believed to
play a key role in the breakdown of this tissue during menstruation
(21, 22, 23). In these studies, P4 increased cad-11
mRNA and protein expression levels in the isolated endometrial stromal
cells within 24 h, suggesting that this gonadal steroid is a key
regulator of this endometrial cell adhesion molecule. In addition, we
have previously determined that cad-11 is first expressed in
endometrial stromal cells beginning to undergo decidualization during
the late secretory phase of the menstrual cycle when
P4 is the predominant steroid (5). Collectively,
these observations suggest that a P4-mediated
increase in stromal cad-11 expression may serve as a useful marker for
the early cellular events involved in the process of decidualization
in vivo and in vitro.
We failed to detect a significant increase in cad-11 expression in
endometrial stromal cells cultured in the presence of the
nonaromatizable androgen, DHT. Furthermore, DHT was not capable of
enhancing the P4-mediated increase in cad-11
expression in endometrial stromal cells. Collectively, these results
demonstrate that androgens are unable to increase stromal cad-11 mRNA
or protein expression levels in either a direct or an indirect manner.
Although androgen receptors have been detected in the human endometrium
and decidua (3), it is still unclear whether androgens play a direct
role in the process of decidualization in the human. For example,
recent studies have demonstrated that DHT alone can induce PRL
secretion in isolated endometrial stromal cells and potentiate the
effects of P4 on the secretion of this
endometrial protein in vitro (4). In addition,
pharmacological doses of DHT were able to maintain, but not initiate,
decidualization in the stromal cells of the mouse uterus (24). However,
the actions of DHT on the rodent endometrium could be suppressed by the
anti-progestin, RU486, suggesting that the actions of this androgen on
the murine decidua were mediated by its ability to interact with the
P4 receptor (24).
E2 did not increase cad-11 mRNA or protein levels
in isolated endometrial stromal cells, suggesting that this gonadal
steroid does not have a direct effect on stromal cad-11 expression.
Similarly, previous studies have failed to demonstrate a direct effect
of this gonadal steroid on the production of the two decidual cell
markers, PRL and insulin-like growth factor-binding protein-1 (10), or
the secretion of metalloproteinases by endometrial stromal cells
in vitro (21). Furthermore, although
E2 is essential for the synthesis of specific
proteins in the endometrium, including P4 and
E2 receptors, depleted levels of this gonadal
steroid during the luteal phase of the menstrual cycle do not appear to
effect endometrial development in vivo (25). To date, the
role(s) of E2 in the differentiation of
endometrial stromal cells in vivo and in vitro
remain poorly understood.
E2 was capable of potentiating the stimulatory
effects of P4 on cad-11 mRNA and protein levels
in isolated endometrial stromal cells, suggesting that this gonadal
steroid has an indirect effect on stromal cad-11 expression. Maximum
levels of insulin-like growth factor-binding protein-1 and PRL have
also been detected in endometrial stromal cells cultured in the
presence of both E2 and P4
(11). However, Grosskinsky et al. (26) failed to detect an
increase in the expression of integrin subunits in endometrial stromal
cells cultured in the presence of these two gonadal steroids despite
observing an increase in PRL production in these cell cultures. As the
differential expression of several integrin subunits in the human
endometrium during the secretory phase of the menstrual cycle appears
to be required for successful implantation (27), these observations
indicate that the process of decidualization is a complex series of
hormonally dependent and independent events. To date, the cellular
mechanisms involved at the different stages of this developmental
process remain poorly defined.
The mechanism(s) by which E2 enhances the effects
of P4 on endometrial stromal cell differentiation
have not been determined. However, several mechanisms have been
recently proposed. For example, as E2 has been
shown to induce P4 receptors in human endometrial
stromal cells in vivo and in vitro (28), the
effects of E2 on the terminal differentiation of
endometrial stromal cells may be mediated by an increase in
P4 availability. Although this proposed mechanism
could explain the ability of E2 to enhance the
P4-mediated increase in stromal cad-11, the
effects of gonadal steroids are also believed to be mediated through
growth factors (29). In particular, the effects of
E2 on endometrial cells have been shown to be
mediated at least in part by an increase in the levels of epidermal
growth factor. Furthermore, Somkuti et al. (30) have
recently suggested that a combination of gonadal steroids and epidermal
growth factor is required for the spatiotemporal expression of integrin
subunits in human endometrial cells. The ability of growth factors,
alone or in combination with gonadal steroids, to regulate cad-11 in
human endometrial cells has not been determined. In view of these
observations, we are currently examining potential mechanisms by which
E2 enhances the effects of
P4 on cad-11 expression in isolated endometrial
stromal cells.
In summary, our findings demonstrate that P4, but
not E2 or DHT, is capable of regulating cad-11
mRNA and protein expression levels in isolated endometrial stromal
cells. However, E2 in conjunction with
P4 appears to be necessary to achieve maximal
cad-11 expression in these cells. In view of these observations, it is
tempting to speculate that the ability of steroids to regulate the
terminal differentiation of endometrial stromal cells into decidual
cells is mediated at least in part by their ability to regulate cad-11
expression.
 |
Acknowledgments
|
|---|
The authors thank Dr. M. D. Stephenson, Department of
Obstetrics and Gynecology, University of British Columbia, for
providing the endometrial biopsy specimens and the ICOS Corp. (Bothell,
WA) for their kind gift of the monoclonal antibody used in these
studies. We are grateful to Dr. Riaz Farookhi, Department of Obstetrics
and Gynecology, McGill University (Montreal, Canada) for carefully
reading this manuscript and for his helpful comments.
 |
Footnotes
|
|---|
1 This work was supported by a grant from the Medical Research Council
of Canada (to C.D.M.), a scholarship from the Medical Research Council
of Canada (to C.D.M.), and a Graduate Fellowship from the University of
British Columbia (to S.G.). Research on human subjects was approved by
the Committee for Ethical Review of Research Involving Human Subjects,
University of British Columbia, Vancouver, Canada. All subjects
provided informed consent for these studies. 
Received January 22, 1998.
 |
References
|
|---|
-
Noyes RW, Hertig AT, Rock J 1950 Dating the
endometrial biopsy. Fertil Steril 1:325
-
Clark JH, Markaverich B, Upchurch S, Eriksson H, Hardin
JW, Peck Jr E 1980 Heterogeneity of estrogen binding sites:
relationship to estrogen receptors and estrogen responses. Recent Prog
Horm Res 36:89134
-
Horie K, Takakura K, Imai K, Liao S, Mori T 1992 Immunohistochemical localization of androgen receptor in the human
endometrium, decidua, placenta and pathological conditions of the
endometrium. Hum Reprod 7:14611466[Abstract/Free Full Text]
-
Narukawa S, Kanzaki H, Inoue T, Imai K, Higuchi T,
Hatayama H, Kariya M, Mori T 1994 Androgens induce prolactin
production by human endometrial stromal cells in vitro.
J Clin Endocrinol Metab 78:165168[Abstract]
-
MacCalman CD, Furth EE, Omigbodun A, Bronner M,
Coutifaris C, Strauss III JF 1996 Regulated expression of
cadherin-11 in human epithelial cells: a role for cadherin-11 in
trophoblast-endometrium interactions? Dev Dyn 206:201211[CrossRef][Medline]
-
MacCalman CD, Omigbodun A, Tian XC, Fortune JE, Furth
EE, Coutifaris C, Strauss III JF 1996 Novel cell adhesion
molecules: roles in implantation? In: Beier HM, Harper MJK, Chwalisz K
(eds) The Endometrium as a Target for Contraception. Springer Verlag,
Berlin, pp 137157
-
MacCalman CD, Farookhi R, Blaschuk OW 1994 Estradiol and progesterone regulate E-cadherin mRNA levels in the mouse
uterus. Endocr J 2:485490
-
MacCalman CD, Farookhi R, Blaschuk OW 1995 Estradiol regulates N-cadherin mRNA levels in the mouse ovary. Dev
Genet 16:2024[CrossRef][Medline]
-
MacCalman CD, Blaschuk OW 1994 Gonadal steroids
regulate N-cadherin mRNA levels in the mouse testis. Endocrine 2:157163
-
Osteen KG, Hill GA, Hargrove JT, Gorstein F 1989 Development of a method to isolate and culture highly purified
populations of stromal and epithelial cells from human endometrial
biopsy specimens. Fertil Steril 52:965972[Medline]
-
Irwin JC, Kirk D, King RJ, Quigley MM, Gwatkin RB 1989 Hormonal regulation of human endometrial stromal cells in culture:
an in vitro model for decidualization. Fertil Steril 52:761768[Medline]
-
Shiokawa S, Yoshimura Y, Nagamatsu S, Sawa H, Hanashi H,
Oda T, Katsumata Y, Koyama N, Nakamura Y 1996 Expression of ß1
integrins in human endometrial stromal and decidual cells. J Clin
Endocrinol Metab 81:153315340[Abstract]
-
Castelbaum AJ, Ying L, Somkuti SG, Sun J, Ilesanmi AO,
Lessey BA 1997 Characterization of integrin expression in a well
differentiated endometrial adenocarcinoma cell line (Ishikawa). J
Clin Endocrinol Metab 82:136142[Abstract/Free Full Text]
-
Chomczynski P, Sacchi N 1987 Single-step method of
RNA isolation by acid guanidinium thiocyanate-phenol-chloroform
extraction. Anal Biochem 162:156159[Medline]
-
MacCalman CD, Bardeesy N, Holland PC, Blaschuk OW 1992 Noncoordinate developmental regulation of N-cadherin, N-CAM,
integrin, and fibronectin mRNA levels during myoblast terminal
differentiation. Dev Dyn 195:127132[Medline]
-
Laemmli UK 1970 Cleavage of structural proteins
during the assembly of the head of bacteriophage T4. Nature 227:680685[CrossRef][Medline]
-
Towbin H, Staehelin T, Gordon J 1979 Electrophoretic transfer of proteins from polyacrylamide gels to
nitrocellulose sheets: procedure and some applications. Proc Natl Acad
Sci USA 76:43504354[Abstract/Free Full Text]
-
Getsios S, Chen GTC, Stephenson MD, LeClerc P, Blaschuk
OW, MacCalman CD 1998 Regulated expression of cadherin-6 and
cadherin-11 in the glandular epithelial and stromal cells of human
endometrium. Dev Dyn 211:238247[CrossRef][Medline]
-
Zhu HH, Huang JR, Mazela J, Elias J, Tseng L 1992 Progestin stimulates the biosynthesis of fibronectin and accumulation
of fibronectin mRNA in human endometrial stromal cells. Hum Reprod 7:141146[Abstract/Free Full Text]
-
Aplin JD, Charlton AK, Ayad S 1988 An
immunohistochemical study of human endometrial extracellular matrix
during the menstrual cycle and first trimester of pregnancy. Cell
Tissue Res 253:231240[Medline]
-
Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F,
Matrisian LM 1994 Stromal-epithelial interaction mediates
steroidal regulation of metalloproteinase expression in human
endometrium. Proc Natl Acad Sci USA 91:1012910133[Abstract/Free Full Text]
-
Irwin JC, Kirk D, Gwatkin RBL, Navre M, Cann 0n P,
Giudice LC 1996 Human endometrial matrix metalloproteinase-2, a
putative menstrual proteinase. J Clin Invest 97:438447[Medline]
-
Salamonsen LA, Butt AR, Hammond FR, Garcia S, Zhang
J 1997 Production of endometrial matrix metalloproteinases, but
not their tissue inhibitors, is modulated by progesterone withdrawal in
an in vitro model for menstruation. J Clin Endocrinol
Metab 82:14091415[Abstract/Free Full Text]
-
Zhang X, Croy BA 1996 Maintenance of decidual cell
reaction by androgens in the mouse. Biol Reprod 55:519524[Abstract]
-
Younis JS, Ezra Y, Sherman Y, Simon A, Schenker JG,
Laufer N 1994 The effect of estradiol depletion during the luteal
phase on endometrial development. Fertil Steril 62:103107[Medline]
-
Grosskinsky CM, Yowell CW, Sun J, Parise LV, Lessey
BA 1996 Modulation of integrin expression in endometrial stromal
cells in vitro. J Clin Endocrinol Metab 81:20472054[Abstract]
-
Lessey BA, Ilesnami AO, Lessey MA, Riben M, Harris JE,
Chwalisz K 1997 Luminal and glandular endometrial epithelium
express integrins differentially throughout the menstrual cycle:
implications for implantation, contraception, and fertility. Am J
Reprod Immunol 35:195204
-
Eckert RL, Katzenellenbogen BS 1981 Human
endometrial cells in primary tissue culture: modulation of the
progesterone receptor level by natural and synthetic estrogens in
vitro. J Clin Endocrinol Metab 52:699708[Abstract/Free Full Text]
-
Giudice LC 1994 Growth factors and growth
modulators in human uterine endometrium: their potential relevance to
reproductive medicine. Fertil Steril 61:117[Medline]
-
Somkuti SG, Yuan LW, Fritz MA, Lessey BA 1997 Epidermal growth factor and sex steroids dynamically regulate a marker
of endometrial receptivity in Ishikawa cells. J Clin Endocrinol
Metab 82:21922197[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
J. Wen, H. Zhu, S. Murakami, P. C. K. Leung, and C. D. MacCalman
Regulation of A Disintegrin And Metalloproteinase with ThromboSpondin Repeats-1 Expression in Human Endometrial Stromal Cells by Gonadal Steroids Involves Progestins, Androgens, and Estrogens
J. Clin. Endocrinol. Metab.,
December 1, 2006;
91(12):
4825 - 4835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Wiebe, D. Muzia, J. Hu, D. Szwajcer, S. A. Hill, and J. L. Seachrist
The 4-Pregnene and 5{{alpha}}-Pregnane Progesterone Metabolites Formed in Nontumorous and Tumorous Breast Tissue Have Opposite Effects on Breast Cell Proliferation and Adhesion
Cancer Res.,
February 1, 2000;
60(4):
936 - 943.
[Abstract]
[Full Text]
|
 |
|